Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Serum adiponectin levels in patients with coronary artery disease.

Fayyaz I, Ahmed MZ, Shah SI, Mehmood S, Akram S, Ghani M.

J Ayub Med Coll Abbottabad. 2009 Oct-Dec;21(4):90-2.

PMID:
21067035
2.

Adiponectin serum concentrations in men with coronary artery disease: the LUdwigshafen RIsk and Cardiovascular Health (LURIC) study.

Pilz S, Maerz W, Weihrauch G, Sargsyan K, Almer G, Nauck M, Boehm BO, Winkelmann BR, Mangge H; LUdwigshafen RIsk and Cardiovascular Health (LURIC) Group..

Clin Chim Acta. 2006 Feb;364(1-2):251-5. Epub 2005 Aug 18.

PMID:
16111669
3.

The effect of 6 months of treatment with pravastatin on serum adiponection concentrations in Japanese patients with coronary artery disease and hypercholesterolemia: a pilot study.

Sakamoto K, Sakamoto T, Ogawa H; Kumamoto Joint Research on Hypercholesterolemia Investigators..

Clin Ther. 2006 Jul;28(7):1012-21.

PMID:
16990079
4.

Adiponectin--its potential to predict and prevent coronary artery disease.

Skrabal CA, Czaja J, Honz K, Emini R, Hannekum A, Friedl R.

Thorac Cardiovasc Surg. 2011 Jun;59(4):201-6. doi: 10.1055/s-0030-1250211. Epub 2011 Mar 17.

PMID:
21416461
5.

Serum adipocyte fatty acid binding proteins and adiponectin in patients with coronary artery disease: the significance of A-FABP/adiponectin ratio.

Jin J, Peng DQ, Yuan SG, Zhao SP, Ning XH, Wang SH, Li SL.

Clin Chim Acta. 2010 Nov 11;411(21-22):1761-5. doi: 10.1016/j.cca.2010.07.031. Epub 2010 Aug 2.

PMID:
20688054
6.

Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.

Yaturu S, Daberry RP, Rains J, Jain S.

Cytokine. 2006 May;34(3-4):219-23. Epub 2006 Jul 5.

PMID:
16822679
7.

Decreased levels of plasma adiponectin in prediabetes, Type 2 diabetes and coronary artery disease.

Yaturu S, Bridges JF, Subba Reddy DR.

Med Sci Monit. 2006 Jan;12(1):CR17-20. Epub 2005 Dec 19.

PMID:
16369465
8.

Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study.

Schnabel R, Messow CM, Lubos E, Espinola-Klein C, Rupprecht HJ, Bickel C, Sinning C, Tzikas S, Keller T, Genth-Zotz S, Lackner KJ, Münzel TF, Blankenberg S.

Eur Heart J. 2008 Mar;29(5):649-57. doi: 10.1093/eurheartj/ehn009. Epub 2008 Feb 9.

PMID:
18263867
9.
10.

High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease.

Inoue T, Kotooka N, Morooka T, Komoda H, Uchida T, Aso Y, Inukai T, Okuno T, Node K.

Am J Cardiol. 2007 Aug 15;100(4):569-74. Epub 2007 Jun 29.

PMID:
17697807
11.

Association of hypoadiponectinemia with coronary artery disease in men.

Kumada M, Kihara S, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Hiraoka H, Nakamura T, Funahashi T, Matsuzawa Y; Osaka CAD Study Group. Coronary artery disease..

Arterioscler Thromb Vasc Biol. 2003 Jan 1;23(1):85-9.

12.

[Cystatin C and adiponectin in diabetics with and without coronary artery disease].

Wolff C, Durruty P, Espinoza J, Ripamonti S, Díaz J.

Rev Med Chil. 2009 Jun;137(6):729-36. doi: /S0034-98872009000600001. Epub 2009 Sep 4. Spanish.

13.

Comparison of serum high-molecular weight (HMW) adiponectin with total adiponectin concentrations in type 2 diabetic patients with coronary artery disease using a novel enzyme-linked immunosorbent assay to detect HMW adiponectin.

Aso Y, Yamamoto R, Wakabayashi S, Uchida T, Takayanagi K, Takebayashi K, Okuno T, Inoue T, Node K, Tobe T, Inukai T, Nakano Y.

Diabetes. 2006 Jul;55(7):1954-60.

14.

Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels.

Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, Vitale D, Tritapepe L, Letizia C.

Horm Metab Res. 2009 Mar;41(3):227-31. doi: 10.1055/s-0028-1100412. Epub 2008 Nov 10. Erratum in: Horm Metab Res. 2009 Mar;41(3):259. di Gioia, C R Tiziana [corrected to di Gioia, Cira Rosaria Tiziana].

PMID:
19003726
15.

Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.

Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT.

Int J Obes (Lond). 2008 Feb;32(2):268-74. Epub 2007 Sep 18.

PMID:
17878891
16.

Adiponectin isoforms are not associated with the severity of coronary atherosclerosis but with undiagnosed diabetes in patients affected by stable CAD.

Rizza S, Clementi F, Porzio O, Cardellini M, Savo A, Serino M, Chiricolo G, Romeo F, Lauro R, Federici M.

Nutr Metab Cardiovasc Dis. 2009 Jan;19(1):54-60. doi: 10.1016/j.numecd.2007.12.001. Epub 2008 May 9.

PMID:
18472407
17.

Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease.

Ohashi K, Ouchi N, Kihara S, Funahashi T, Nakamura T, Sumitsuji S, Kawamoto T, Matsumoto S, Nagaretani H, Kumada M, Okamoto Y, Nishizawa H, Kishida K, Maeda N, Hiraoka H, Iwashima Y, Ishikawa K, Ohishi M, Katsuya T, Rakugi H, Ogihara T, Matsuzawa Y.

J Am Coll Cardiol. 2004 Apr 7;43(7):1195-200.

18.

ADIPOQ and adiponectin: the common ground of hyperglycemia and coronary artery disease?

Oliveira CS, Giuffrida FM, Crispim F, Saddi-Rosa P, Reis AF.

Arq Bras Endocrinol Metabol. 2011 Oct;55(7):446-54. Review.

19.

Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis.

Saely CH, Risch L, Hoefle G, Rein P, Muendlein A, Marte T, Aczel S, Langer P, Drexel H.

Clin Chim Acta. 2007 Aug;383(1-2):97-102. Epub 2007 May 10.

PMID:
17550784
20.

Combination of serum adiponectin level and metabolic syndrome is closely associated with coronary artery disease in Japanese subjects with good glycemic control.

Yamashita T, Matsuda M, Nishimoto O, Nakamoto K, Nishiyama H, Matsumoto K, Tamura R, Kawamoto T.

Intern Med. 2010;49(8):721-7. Epub 2010 Apr 15.

Supplemental Content

Support Center